Archives
-
Acetylcholine Chloride: Optimizing Cholinergic Signaling Ass
2026-05-13
Acetylcholine Chloride empowers researchers to dissect gut-brain cholinergic pathways, unlocking translational insights for epilepsy and neural circuit modulation. This article details best practices, troubleshooting, and protocol precision for leveraging APExBIO’s high-purity reagent in advanced neurobiology and microbiome research.
-
Induction of Right Ventricular Cardiomyocytes from hPSCs
2026-05-12
Saito et al. present a refined differentiation protocol that enables the specific generation of right ventricular-like cardiomyocytes from human pluripotent stem cells. This innovation provides a platform for chamber-specific heart disease modeling and enhances understanding of right ventricular pathology.
-
Alternariol Induces Liver Fibrosis via Stellate Cell Activat
2026-05-12
This study uncovers how Alternariol (AOH) and related Alternaria toxins drive the transdifferentiation of hepatic stellate cells into myofibroblasts, a key event in liver fibrosis. Through omics-guided analysis, it reveals activation of NF-κB, ferroptosis, and autophagy pathways, and introduces CotA laccase as a candidate for mycotoxin detoxification.
-
Quizartinib (AC220): Optimizing Selective FLT3 Inhibition in
2026-05-11
Quizartinib (AC220) empowers acute myeloid leukemia research with nanomolar FLT3 inhibition and robust selectivity, offering unmatched utility in both in vitro and in vivo models. This guide translates recent advances—such as targeting FLT3-driven resistance—into practical protocols, troubleshooting strategies, and comparative insights for highly reproducible results.
-
Rottlerin: Precision PKCδ Inhibition for Translational Impac
2026-05-11
Explore how Rottlerin, a selective PKCδ inhibitor, transforms translational research by bridging mechanistic insight with evidence-based guidance. This article dissects its role in modulating cell proliferation, apoptosis, and viral entry, connecting peer-reviewed findings with workflow optimization and competitive positioning for advanced applications.
-
Dehydroepiandrosterone (DHEA): Optimizing Neuroprotection an
2026-05-10
Leverage Dehydroepiandrosterone (DHEA) for robust models in neuroprotection and ovarian biology, with protocol-ready parameters and troubleshooting tips informed by the latest research. Discover how APExBIO’s DHEA streamlines experimental success, from apoptosis inhibition to granulosa cell proliferation.
-
MAPK10 Phosphorylation of KRT16 Suppresses NSCLC Metastasis
2026-05-09
This study reveals that mitogen-activated protein kinase 10 (MAPK10) inhibits non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). The findings identify the MAPK10/KRT16/RNF213 axis as a potential prognostic biomarker and therapeutic target in NSCLC, opening new avenues for molecular pathway research and intervention.
-
EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC: Chemo
2026-05-08
This study pioneers a chemogenetic screening strategy to identify synthetic lethal targets in MYC-driven triple-negative breast cancer (TNBC), pinpointing EphA2 inhibition as a promising vulnerability. The findings highlight the therapeutic potential of targeting EphA2 in aggressive, MYC-activated TNBC, with robust experimental validation and translational implications.
-
CHI3L1-IN-5 (Compound Z17): Optimizing Neuroinflammation Ass
2026-05-08
CHI3L1-IN-5 (Compound Z17) empowers translational research by uniquely enabling both suppression of CHI3L1-mediated NF-κB signaling and restoration of amyloid-beta clearance in astrocytes. This protocol-centric guide translates recent mechanistic advances into robust workflows for modeling and modulating neuroinflammatory cascades in Alzheimer's disease.
-
Latrunculin A: Reversible Inhibitor of Actin Assembly in Res
2026-05-07
Latrunculin A empowers high-precision, reversible actin cytoskeleton disruption for advanced cell morphology and virology studies. Learn how recent proteomic insights and optimized protocols elevate reproducibility and mechanistic clarity in cytoskeletal and host-pathogen research.
-
DOT1L Inhibition Enhances Immunomodulatory Drug Response in
2026-05-07
This study demonstrates that inhibition of DOT1L reprograms innate immune signaling in multiple myeloma (MM), leading to potentiation of immunomodulatory drug (IMiD) efficacy. By dissecting the mechanistic interplay between DOT1L, interferon signaling, and DNA damage pathways, the research identifies DOT1L as a critical epigenetic target for overcoming therapeutic resistance in MM.
-
Chemically Modified SOD2 mRNA-LNPs Mitigate Renal IRI in Mic
2026-05-06
This study demonstrates that lipid nanoparticle (LNP)-delivered, chemically modified SOD2 mRNA can significantly reduce renal injury following ischemia-reperfusion in mice. By leveraging optimized mRNA design and delivery, the research offers mechanistic and translational insight into mRNA therapeutics for acute kidney injury.
-
Erastin as a Ferroptosis Inducer: Mechanisms, Protocols, and
2026-05-06
Explore how Erastin, a potent ferroptosis inducer, advances cancer biology research and immunotherapy. This article uniquely details the immunological synergy and protocol nuances that set Erastin apart.
-
Mechanical Forces Activate GABAB Receptor Independent of GAB
2026-05-05
This study uncovers a novel, ligand-independent mechanism for GABAB receptor activation, showing that mechanical forces such as shear stress directly induce receptor signaling via integrin-GB1 interactions. These insights expand our understanding of mechanotransduction in the central nervous system and highlight new research avenues for cytoskeletal and signaling studies.
-
Bestatin (Ubenimex): Advanced Workflows for Aminopeptidase I
2026-05-05
Bestatin (Ubenimex) from APExBIO empowers researchers to precisely measure and manipulate aminopeptidase activity in cancer and multidrug resistance studies. This guide delivers actionable protocol parameters, troubleshooting strategies, and a translational bridge from angiogenesis research to practical bench workflows.